Progyny, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Progyny, Inc. (PGNY) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $46.46 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-03-01
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$4.40M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$8.21M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was $1.52M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was $2.52M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was $46.46M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was -$8.57M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was -$5.12M.
- Progyny, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was -$12.46M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-12-31 | $46.46M 10-K · filed 2021-03-01 | |||
| 2019-12-31 | -$4.40M 10-K · filed 2020-03-10 | -$12.61M derived: sum of 2 quarters · filed 2020-03-10 | -$11.09M derived: sum of 3 quarters · filed 2020-03-10 | -$8.57M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$8.21M 10-K · filed 2020-03-10 | -$6.69M derived: sum of 2 quarters · filed 2020-03-10 | -$4.17M 10-Q · filed 2019-12-06 | -$5.75M derived: sum of 4 quarters · filed 2020-03-10 |
| 2019-06-30 | $1.52M 10-K · filed 2020-03-10 | $4.04M derived: sum of 2 quarters · filed 2020-03-10 | $2.46M derived: sum of 3 quarters · filed 2020-03-10 | $1.33M derived: sum of 4 quarters · filed 2020-03-10 |
| 2019-03-31 | $2.52M 10-K · filed 2020-03-10 | $944.00K derived: sum of 2 quarters · filed 2020-03-10 | -$193.00K derived: sum of 3 quarters · filed 2020-03-10 | -$1.02M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-12-31 | -$1.58M 10-K · filed 2020-03-10 | -$2.71M derived: sum of 2 quarters · filed 2020-03-10 | -$3.54M derived: sum of 3 quarters · filed 2020-03-10 | -$5.12M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$1.14M 10-K · filed 2020-03-10 | -$1.97M derived: sum of 2 quarters · filed 2020-03-10 | -$3.54M 10-Q · filed 2019-12-06 | |
| 2018-06-30 | -$831.00K 10-K · filed 2020-03-10 | -$2.40M derived: sum of 2 quarters · filed 2020-03-10 | ||
| 2018-03-31 | -$1.57M 10-K · filed 2020-03-10 | |||
| 2017-12-31 | -$12.46M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |